Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists
Authors:
- Christoph EnzenspergerCEChristoph Enzensperger
- Susann KilianSKSusann Kilian
- Marit AckermannMAMarit Ackermann
- Anne KochAKAnne Koch
- Kristin KelchKKKristin Kelch
- Jochen LehmannJLJochen Lehmann
- 1 March 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1399-1402
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Dopamine/Serotonin Receptor Ligands. 13: Homologization of a Benzindoloazecine-Type Dopamine Receptor Antagonist Modulates the Affinities for Dopamine D1−D5 ReceptorsJournal of Medicinal Chemistry, 2006
- Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysisBMC Pharmacology, 2006
- Dopamine/Serotonin Receptor Ligands. 12: SAR Studies on Hexahydro-dibenz[d,g]azecines Lead to 4-Chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the First Picomolar D5-Selective Dopamine-Receptor AntagonistJournal of Medicinal Chemistry, 2006
- Dopamine/Serotonin Receptor Ligands. 10: SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D1, D2L, and D5 Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D1/D5 Selective AntagonistJournal of Medicinal Chemistry, 2005
- Dopamine/serotonin receptor ligands. Part VIII[1]:the dopamine receptor antagonist LE300 - modelled and X-ray structure plus further pharmacological characterization, including serotonin receptor binding, biogenic amine transporter testing and in vivo testingsEuropean Journal of Medicinal Chemistry, 2004
- Dopamine Receptor Ligands. Part VII [1]: Novel 3-Substituted 5-Phenyl-1, 2, 3, 4, 5, 6-hexahydro-azepino-[4, 5-b]indoles as Ligands for the Dopamine ReceptorsArchiv der Pharmazie, 2003
- 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: A New Heterocyclic System and a New Lead Compound for Dopamine Receptor AntagonistsJournal of Medicinal Chemistry, 2000
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973